Provided herein are biomarkers useful for determining weakness, biomarker markers of weakness, and methods of identifying, classifying, and treating weakness subjects using biomarkers. Also provided herein are biomarkers for the determination, identification, classification, and treatment of conditions associated with altered physical reserve, physical ability, and athletic ability.
Use of GDF-15 in diagnosis and treatment of weakness and conditions associated with altered physiological reserve, physical ability and athletic ability